|
Sign In to gain access to subscriptions and/or personal tools.
|
The pathology of primary progressive multiple sclerosis
W Brück
Department of Neuropathology, Charité, Campus Virchow-Klinikum, Augustenburger Platz 1, Berlin D-13353, Germany, wolfgang.brueck{at}charite.de
C Lucchinetti
Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA
H Lassmann
Department of Neuroimmunology, Brain Research Institute, Spitalgasse 4, Vienna 1090, Austria
The present review will focus on the current knowledge of the pathology of primary progressive multiple sclerosis lesions. Multiple sclerosis (MS) is an inflammatory demyelinating disease with a broad clinical variability. The main disease courses are relapsing-remitting, secondary progressive and primary progressive MS. Pathological studies examining the specific underlying pathology of a defined clinical subtype are rare. Here, we focus on the phatological characteristics of the MS lesions and summarize the current findings of the phatology of primary progressive MS with respect to inflammation, oligodendrocyte/myelin pathology, axon destruction and immunopathology of the lesions.
Key Words: axons demyelination inflammation multiple sclerosis primary progressive
Multiple Sclerosis, Vol. 8, No. 2,
93-97 (2002)
DOI: 10.1191/1352458502ms785rr

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. P. Lisak
Neurodegeneration in multiple sclerosis: Defining the problem
Neurology,
May 29, 2007;
68(22_suppl_3):
S5 - S12.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Camp, V. L. Stevenson, A. J. Thompson, G. T. Ingle, D. H. Miller, C. Borras, B. Brochet, V. Dousset, M. Falautano, M. Filippi, et al.
A longitudinal study of cognition in primary progressive multiple sclerosis
Brain,
December 1, 2005;
128(12):
2891 - 2898.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kutzelnigg, C. F. Lucchinetti, C. Stadelmann, W. Bruck, H. Rauschka, M. Bergmann, M. Schmidbauer, J. E. Parisi, and H. Lassmann
Cortical demyelination and diffuse white matter injury in multiple sclerosis
Brain,
November 1, 2005;
128(11):
2705 - 2712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W Rashid, L M Parkes, G T Ingle, D T Chard, A T Toosy, D R Altmann, M R Symms, P S Tofts, A J Thompson, and D H Miller
Abnormalities of cerebral perfusion in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry,
September 1, 2004;
75(9):
1288 - 1293.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Thompson
Overview of primary progressive multiple sclerosis (PPMS): similarities and differences from other forms of MS, diagnostic criteria, pros and cons of progressive diagnosis
Multiple Sclerosis,
June 1, 2004;
10(1_suppl):
S2 - S7.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Thompson
Overview of primary progressive multiple sclerosis (PPMS): similarities and differences from other forms of MS, diagnostic criteria, pros and cons of progressive diagnosis
Multiple Sclerosis,
May 1, 2004;
10(3_suppl):
S2 - S7.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E. L. Oleszak, J. R. Chang, H. Friedman, C. D. Katsetos, and C. D. Platsoucas
Theiler's Virus Infection: a Model for Multiple Sclerosis
Clin. Microbiol. Rev.,
January 1, 2004;
17(1):
174 - 207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. T. Ingle, V. L. Stevenson, D. H. Miller, and A. J. Thompson
Primary progressive multiple sclerosis: a 5-year clinical and MR study
Brain,
November 1, 2003;
126(11):
2528 - 2536.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. De Stefano, P. M. Matthews, M. Filippi, F. Agosta, M. De Luca, M. L. Bartolozzi, L. Guidi, A. Ghezzi, E. Montanari, A. Cifelli, et al.
Evidence of early cortical atrophy in MS: Relevance to white matter changes and disability
Neurology,
April 8, 2003;
60(7):
1157 - 1162.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Rudick
Mechanisms of disability progression in primary progressive multiple sclerosis: are they different from secondary progressive multiple sclerosis?
Multiple Sclerosis,
April 1, 2003;
9(2):
210 - 212.
[PDF]
|
 |
|
|
|